Loading...
XSTO
AXIC A
Market cap14mUSD
Dec 05, Last price  
2.25SEK
1D
-8.16%
1Q
-42.46%
Jan 2017
-57.55%
IPO
-79.98%
Name

aXichem AB (publ)

Chart & Performance

D1W1MN
XSTO:AXIC A chart
P/E
—
P/S
15.52
EPS
—
Div Yield, %
—
Shrs. gr., 5y
22.86%
Rev. gr., 5y
90.34%
Revenues
9m
+373.74%
000000376,000000344,000343,0001,227,0004,362,0005,007,0001,809,0008,570,000
Net income
-18m
L-14.41%
-1,048,343-1,714,510-2,373,899-2,357,067-3,483,130-3,656,563-5,628,000-7,423,000-6,072,000-7,375,000-9,927,000-12,678,000-13,515,000-15,093,000-17,260,000-20,811,000-17,813,000
CFO
-12m
L-26.62%
7,417,083-2,998,397-1,131,528-428,503-4,885,777-4,293,957-9,014,000-7,977,000-5,526,000-7,688,000-7,461,000-12,294,000-11,694,000-15,595,000-19,098,000-15,677,000-11,503,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, an natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was incorporated in 2007 and is based in Malmö, Sweden.
URL
https://www.axichem.se/
IPO date
Jul 10, 2008
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT